Frank, Rimerman Advisors LLC Procept Bio Robotics Corp Transaction History
Frank, Rimerman Advisors LLC
- $1.4 Billion
- Q2 2024
A detailed history of Frank, Rimerman Advisors LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Frank, Rimerman Advisors LLC holds 122,082 shares of PRCT stock, worth $8.87 Million. This represents 0.53% of its overall portfolio holdings.
Number of Shares
122,082
Previous 192,082
36.44%
Holding current value
$8.87 Million
Previous $9.49 Million
21.44%
% of portfolio
0.53%
Previous 1.83%
Shares
6 transactions
Others Institutions Holding PRCT
# of Institutions
214Shares Held
36.3MCall Options Held
251KPut Options Held
101K-
Vanguard Group Inc Valley Forge, PA4.71MShares$342 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$253 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.81MShares$131 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.75MShares$127 Million0.07% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.37MShares$99.2 Million0.53% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $3.24B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...